BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25057941)

  • 1. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation 
in NSCLC Development].
    Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Regulatory Role of
    Chen F; Zheng Y; Zhou H; Li C
    Cancer Biother Radiopharm; 2024 Apr; 39(3):211-222. PubMed ID: 35802495
    [No Abstract]   [Full Text] [Related]  

  • 3. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer.
    Jabbarzadeh Kaboli P; Chen HF; Babaeizad A; Roustai Geraylow K; Yamaguchi H; Hung MC
    Cancer Lett; 2024 Apr; 588():216780. PubMed ID: 38462033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis.
    Liang H; Wang M
    Onco Targets Ther; 2020; 13():2491-2510. PubMed ID: 32273721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells.
    Hernández-Padilla L; Durán-Maldonado MX; Martínez-Alcantar L; Rodríguez-Zavala JS; Campos-Garcia J
    Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38629372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer.
    Mancini M; Gaborit N; Lindzen M; Salame TM; Dall'Ora M; Sevilla-Sharon M; Abdul-Hai A; Downward J; Yarden Y
    Sci Signal; 2015 Jun; 8(379):ra53. PubMed ID: 26038598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive value of MET deregulation in non-small cell lung cancer.
    Finocchiaro G; Toschi L; Gianoncelli L; Baretti M; Santoro A
    Ann Transl Med; 2015 Apr; 3(6):83. PubMed ID: 25992382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
    Stabile LP; Kumar V; Gaither-Davis A; Huang EH; Vendetti FP; Devadassan P; Dacic S; Bao R; Steinman RA; Burns TF; Bakkenist CJ
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer.
    Siddique AB; Kilgore PCSR; Tajmim A; Singh SS; Meyer SA; Jois SD; Cvek U; Trutschl M; Sayed KAE
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
    Kumar G; Goldberg SN; Wang Y; Velez E; Gourevitch S; Galun E; Ahmed M
    Eur Radiol; 2017 Mar; 27(3):1238-1247. PubMed ID: 27287478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.
    Stabile LP; Lyker JS; Land SR; Dacic S; Zamboni BA; Siegfried JM
    Carcinogenesis; 2006 Aug; 27(8):1547-55. PubMed ID: 16513678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the MET gene for the treatment of non-small-cell lung cancer.
    Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of HGF/MET signaling pathway in EGFR-TKI resistance 
in non-small cell lung cancer].
    Song S; Bi M
    Zhongguo Fei Ai Za Zhi; 2014 Oct; 17(10):755-9. PubMed ID: 25342043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened airway HGF.
    Stabile LP; Rothstein ME; Gubish CT; Cunningham DE; Lee N; Siegfried JM
    J Thorac Oncol; 2014 Sep; 9(9):1285-93. PubMed ID: 25057941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
    Siegfried JM; Gubish CT; Rothstein ME; Queiroz de Oliveira PE; Stabile LP
    Mol Pharmacol; 2007 Sep; 72(3):769-79. PubMed ID: 17550984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
    Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
    Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.